MarketCap
Facebook
X
TelegramQuartalsbericht 2025-Q3
hinzugefügt 22.10.2025
Intuitive Surgical Kurzfristige Verbindlichkeiten 2011-2025 | ISRG
Kurzfristige Verbindlichkeiten Jährlich Intuitive Surgical
| 2024 | 2023 | 2022 | 2021 | 2020 | 2019 | 2018 | 2017 | 2016 | 2015 | 2014 | 2013 | 2012 | 2011 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 1.75 B | 1.66 B | 1.42 B | 1.15 B | 965 M | 1.03 B | 821 M | 704 M | 596 M | 492 M | 501 M | 381 M | 402 M | 321 M |
Alle Zahlen in USD-Währung
Indikatorenreichweite aus Jahresberichten
| Höchstwert | Mindestwert | Durchschnitt |
|---|---|---|
| 1.75 B | 321 M | 871 M |
Kurzfristige Verbindlichkeiten anderer Aktien in der Medizinische Instrumente
| Name | Kurzfristige Verbindlichkeiten | Preis | % 24h | Marktkapitalisierung | Land | |
|---|---|---|---|---|---|---|
 |
Baxter International
BAX
|
6.51 B | $ 19.32 | 1.05 % | $ 9.85 B |  USA |
 |
Becton, Dickinson and Company
BDX
|
8.31 B | $ 196.18 | -0.01 % | $ 56.4 B | USA |
 |
Luminex Corporation
LMNX
|
87.5 M | - | - | $ 1.75 B | USA |
 |
Ekso Bionics Holdings
EKSO
|
7.54 M | $ 5.47 | -0.01 % | $ 110 M | USA |
 |
Akers Biosciences, Inc.
AKER
|
1.53 M | - | -9.52 % | $ 20.6 M | USA |
 |
Antares Pharma, Inc.
ATRS
|
63.2 M | - | - | $ 955 M | USA |
 |
Harvard Bioscience
HBIO
|
26.5 M | $ 0.71 | -1.78 % | $ 30.1 M | USA |
 |
Cantel Medical Corp.
CMD
|
179 M | - | -1.18 % | $ 3.4 B | USA |
 |
CRH Medical Corporation
CRHM
|
11.8 M | - | - | $ 282 M | USA |
 |
Hill-Rom Holdings, Inc.
HRC
|
952 M | - | -0.05 % | $ 10.3 B | USA |
 |
Varian Medical Systems, Inc.
VAR
|
1.85 B | - | -0.02 % | $ 16.3 B | USA |
 |
Repro Med Systems
KRMD
|
4.45 M | $ 6.25 | -3.55 % | $ 285 M | USA |
 |
iRhythm Technologies
IRTC
|
111 M | $ 177.0 | 0.68 % | $ 5.52 B | USA |
 |
ICU Medical
ICUI
|
556 M | $ 148.17 | 0.81 % | $ 3.61 B | USA |
 |
LeMaitre Vascular
LMAT
|
30.6 M | $ 83.95 | -0.46 % | $ 1.88 B | USA |
 |
AtriCure
ATRC
|
73.4 M | $ 40.7 | 0.37 % | $ 1.91 B | USA |
 |
Atrion Corporation
ATRI
|
12.6 K | - | - | $ 810 M | USA |
 |
electroCore
ECOR
|
8.12 M | $ 4.93 | 1.54 % | $ 27.2 K | USA |
 |
Isoray
ISR
|
18.2 M | - | 0.03 % | $ 108 M | USA |
 |
AngioDynamics
ANGO
|
76.2 M | $ 13.12 | -0.3 % | $ 536 M | USA |
 |
Merit Medical Systems
MMSI
|
216 M | $ 87.36 | -0.03 % | $ 5.09 B | USA |
 |
The Cooper Companies
COO
|
1.11 B | $ 82.55 | -0.03 % | $ 16.4 B | USA |
 |
Glaukos Corporation
GKOS
|
74 M | $ 116.08 | -0.56 % | $ 5.62 B | USA |
 |
Haemonetics Corporation
HAE
|
578 M | $ 80.39 | 0.36 % | $ 4.05 B | USA |
 |
InfuSystem Holdings
INFU
|
14.5 M | $ 8.93 | -1.71 % | $ 184 M | USA |
 |
Masimo Corporation
MASI
|
618 M | $ 132.7 | -0.44 % | $ 7.07 B | USA |
 |
OraSure Technologies
OSUR
|
33.5 M | $ 2.43 | - | $ 181 M | USA |
 |
Microbot Medical
MBOT
|
3.79 M | $ 2.16 | -0.88 % | $ 22 M |  Israel |
 |
Milestone Scientific
MLSS
|
3.74 M | $ 0.29 | -1.41 % | $ 23.1 M | USA |
 |
Nephros
NEPH
|
2.11 M | $ 4.98 | -4.78 % | $ 51.7 M | USA |
 |
STERIS plc
STE
|
1.02 B | $ 255.64 | 0.02 % | $ 25.2 B | USA |
 |
NeuroMetrix
NURO
|
1.01 M | - | 5.05 % | $ 9.02 M | USA |
 |
Envista Holdings Corporation
NVST
|
879 M | $ 21.99 | -0.05 % | $ 3.79 B | USA |
 |
Predictive Oncology
POAI
|
3.59 M | - | - | $ 32.4 M | USA |
 |
Pro-Dex
PDEX
|
14.6 M | $ 39.33 | -2.65 % | $ 129 M | USA |
 |
Utah Medical Products
UTMD
|
4.71 M | $ 56.66 | 0.66 % | $ 206 M | USA |
 |
Pulse Biosciences
PLSE
|
6.71 M | $ 14.45 | -2.76 % | $ 694 M | USA |
 |
ResMed
RMD
|
689 M | $ 245.14 | 0.3 % | $ 35.8 B | USA |
 |
DENTSPLY SIRONA
XRAY
|
1.59 B | $ 11.47 | 3.66 % | $ 2.33 B | USA |
 |
Repligen Corporation
RGEN
|
165 M | $ 165.37 | -0.18 % | $ 9.21 M | USA |
 |
BioLife Solutions
BLFS
|
32.7 M | $ 24.95 | -1.81 % | $ 1.15 B | USA |
 |
Stereotaxis
STXS
|
13.2 M | $ 2.46 | 1.23 % | $ 199 M | USA |
 |
STAAR Surgical Company
STAA
|
70.3 M | $ 23.37 | -1.1 % | $ 1.15 B | USA |
 |
Retractable Technologies
RVP
|
8.78 M | $ 0.82 | -0.51 % | $ 24.5 M | USA |
 |
Teleflex Incorporated
TFX
|
649 M | $ 122.75 | 0.7 % | $ 5.75 B | USA |
 |
West Pharmaceutical Services
WST
|
550 M | $ 274.28 | -0.95 % | $ 20 B | USA |